Everyone has been touched by someone struggling with cancer and the pain suffered is immense. Typical pain medications such as opioids are not suitable and often bring severe side effects.
The UK medical cannabis market is growing exponentially, with several nascent companies performing well on the London Stock Exchange. For example, Cellular Goods (£30m), Kanabo (£66m) and MCG Pharma (£78m). We too are working towards an LSE listing.
This current crowd raise provides the opportunity to invest at a market valuation of only £10m.
The raise has been EIS approved by the HMRC enabling all UK investors to receive a 30% tax relief.
Fill out this form & you’ll be redirected to our Investor Portal where you can view our investor presentation and all due diligence documents.